{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:32Z","timestamp":1791812732356,"version":"4.3.4"},"reference-count":59,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>The significant rise in rates of depression and anxiety in children and adolescents coupled with underdiagnosis and undertreatment poses a serious health threat to the pediatric population. The escalating pediatric mental health crisis has been associated with rising suicide rates and attempts, increased deaths due to drug overdose, higher health care costs, and limited access to adequate care. A shortage of mental health resources and specialized providers in both community and institutional settings further exacerbates these challenges. This paucity of care highlights the need for additional support, and pharmacists, as accessible health professionals, can help bridge the gap in pediatric mental health care. Pharmacists play a vital role in pediatric mental health by advocating for and performing mental health screenings for pediatric patients presenting with acute psychological and behavioral health issues across various care settings, including emergency departments, inpatient units and outpatient pharmacies. Additionally, pharmacists enhance the efficacy and safety of psychotropic therapies in children with diagnosed mental health conditions by minimizing drug interactions, optimizing dosing, monitoring for adverse effects, and providing patient and family education. This article serves as a Position Statement of the Pediatric Pharmacy Association (PPA), which strongly advocates for the inclusion of pharmacists as key members of multidisciplinary teams supporting pediatric patients with mental health challenges, emphasizing their critical role in improving patient outcomes. Additionally, PPA advocates for routine mental health screenings for all pediatric patients and recommends utilization of referrals and standardized workflows for managing pediatric mental health conditions and substance use disorders.<\/jats:p>","DOI":"10.5863\/jppt-25-00102","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:05Z","timestamp":1791809465000},"page":"689-704","source":"Crossref","is-referenced-by-count":0,"title":["The Critical Role of Pharmacists in Addressing the Pediatric Mental Health Crisis: A Pediatric Pharmacy Association Position Paper"],"prefix":"10.5863","volume":"31","author":[{"given":"Sarah E.","family":"Kubes","sequence":"first","affiliation":[{"name":"College of Pharmacy (SEK), The University of Texas at Austin, Austin, TX"},{"name":"Department of Pharmacotherapy and Pharmacy Services (SEK), University Health, San Antonio, TX"},{"name":"Pharmacotherapy Education and Research Center (SEK), The University of Texas Health Science Center San Antonio, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Stoffella","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Medication Safety (SS), University of San Francisco (UCSF) Medical Center, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly","family":"Buzzeo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (KB, BG), Lee Health - Golisano Children\u2019s Hospital of Southwest Florida, Fort Myers, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Pharmacy (AC), Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gallaher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (KB, BG), Lee Health - Golisano Children\u2019s Hospital of Southwest Florida, Fort Myers, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u00e1n Linh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (ALN), Children\u2019s Hospital of The King\u2019s Daughters, Norfolk, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services (SMB), Geisinger Medical Center, Danville, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"key":"JPPT-25-00102-b01","article-title":"Pediatric mental health crisis is top patient safety threat","year":"2023","unstructured":"Emergency Care Research Institute. Pediatric mental health crisis is top patient safety threat. Plymouth Meeting, PA: 2023. Published March 13, 2023. Accessed April 2, 2025. https:\/\/home.ecri.org\/blogs\/ecri-news\/pediatric-mental-health-crisis-is-top-patient-safety-threat"},{"issue":"7","key":"JPPT-25-00102-b02","series-title":"JAMA Pediatr","first-page":"e220056","article-title":"Five-year trends in US children\u2019s health and well-being, 2016-2020","volume":"176","author":"Lebrun-Harris","year":"2022","unstructured":"Lebrun-Harris LA, Ghandour RM, Kogan MD, et al. Five-year trends in US children\u2019s health and well-being, 2016-2020. JAMA Pediatr. 2022;176(7):e220056."},{"key":"JPPT-25-00102-b03","article-title":"Top 10 patient safety concerns 2023. Plymouth Meeting, PA: 2023","unstructured":"Emergency Care Research Institute. Top 10 patient safety concerns 2023. Plymouth Meeting, PA: 2023. Accessed April 2, 2025. https:\/\/home.ecri.org\/blogs\/ecri-thought-leadership-resources\/top-10-patient-safety-concerns-2023-special-report"},{"key":"JPPT-25-00102-b04","article-title":"The state of mental health in America: 2023","author":"Reinert","year":"2023","unstructured":"Mental Health America. Reinert M, Fritze D, Nguyen T. The state of mental health in America: 2023. Alexandria, VA: 2023. Accessed April 2, 2025. https:\/\/mhanational.org\/the-state-of-mental-health-in-america\/archived-reports"},{"issue":"24","key":"JPPT-25-00102-b05","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"888","article-title":"Emergency department visits for suspected suicide attempts among persons aged 12\u201325 years before and during the COVID-19 pandemic\u2014United States, January 2019\u2013May 2021","volume":"70","author":"Yard","year":"2021","unstructured":"Yard E, Radhakrishnan L, Ballesteros MF, et al. Emergency department visits for suspected suicide attempts among persons aged 12\u201325 years before and during the COVID-19 pandemic\u2014United States, January 2019\u2013May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(24):888\u2013894."},{"key":"JPPT-25-00102-b06","first-page":"2023","article-title":"Suicide and homicide rates increase among young Americans","unstructured":"US Centers for Disease Control and Prevention - National Center for Health Statistics. Tsai B. Suicide and homicide rates increase among young Americans. Hyattsville, MD: 2023. Published June 15,2023. Accessed April 9, 2025. https:\/\/blogs.cdc.gov\/nchs\/2023\/06\/15\/7396\/"},{"issue":"14","key":"JPPT-25-00102-b07","series-title":"JAMA","first-page":"1398","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021","volume":"327","author":"Friedman","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, et al. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398\u20131400."},{"issue":"50","key":"JPPT-25-00102-b08","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"1576","article-title":"Drug overdose deaths among persons aged 10\u201319 years\u2014United States, July 2019\u2013December 2021","volume":"71","author":"Tanz","year":"2022","unstructured":"Tanz LJ, Dinwiddie AT, Mattson CL, et al. Drug overdose deaths among persons aged 10\u201319 years\u2014United States, July 2019\u2013December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(50):1576\u20131582."},{"key":"JPPT-25-00102-b09","article-title":"AAP-AACAP-CHA Declaration of a national emergency in child and adolescent mental health","year":"2021","unstructured":"American Academy of Pediatrics (AAP). AAP-AACAP-CHA Declaration of a national emergency in child and adolescent mental health. Itasca, IL: 2021. Accessed May 22, 2026. https:\/\/www.aacap.org\/App_Themes\/AACAP\/Docs\/press\/Declaration_National_Crisis_Oct-2021.pdf"},{"issue":"3","key":"JPPT-25-00102-b10","series-title":"Child Adolesc Psychiatr Clin N Am","first-page":"277","article-title":"The declaration of the national emergency in child and adolescent mental health: it takes a village","volume":"33","author":"Benton","year":"2024","unstructured":"Benton TD, Beers L, Carlson G, Kee Ng WY. The declaration of the national emergency in child and adolescent mental health: it takes a village. Child Adolesc Psychiatr Clin N Am. 2024;33(3):277\u2013291."},{"key":"JPPT-25-00102-b11","series-title":"Glob Pediatr","first-page":"e1","article-title":"The pivotal role of mental health in child and adolescent development","volume":"13","author":"Suppiej","year":"2025","unstructured":"Suppiej A, Longo I, Pettoello-Mantovani M. The pivotal role of mental health in child and adolescent development. Glob Pediatr. 2025;13:e1\u2013e8."},{"key":"JPPT-25-00102-b12","article-title":"Statistical brief #440: Expenditures for treatment of mental health disorders among children, ages 5\u201317, 2009\u20132011: estimates for the US civilian noninstitutionalized population","author":"Davis","year":"2014","unstructured":"Agency for Healthcare Research and Quality [AHRQ]. Davis KE. Statistical brief #440: Expenditures for treatment of mental health disorders among children, ages 5\u201317, 2009\u20132011: estimates for the US civilian noninstitutionalized population. Rockville, MD: 2014. Published June 2014. Accessed April 30, 2024. http:\/\/www.meps.ahrq.gov\/mepsweb\/data_files\/publications\/st440\/stat440.shtml"},{"issue":"3","key":"JPPT-25-00102-b13","series-title":"JAMA Netw Open","first-page":"e241860","article-title":"Medical spending among US households with children with a mental health condition between 2017 and 2021","volume":"7","author":"Loo","year":"2024","unstructured":"Loo TM, Altman M, Bravata DM, et al. Medical spending among US households with children with a mental health condition between 2017 and 2021. JAMA Netw Open. 2024;7(3):e241860."},{"issue":"3","key":"JPPT-25-00102-b14","series-title":"Pediatrics","first-page":"e2023063255","article-title":"The management of children and youth with pediatric mental and behavioral health emergencies","volume":"152","author":"Saidinejad","year":"2023","unstructured":"Saidinejad M, Duffy S, Wallin D, et al. The management of children and youth with pediatric mental and behavioral health emergencies. Pediatrics. 2023;152(3):e2023063255."},{"issue":"2","key":"JPPT-25-00102-b15","series-title":"Int J Clin Pharm","first-page":"222","article-title":"A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health","volume":"36","author":"Richardson","year":"2014","unstructured":"Richardson TE, O\u2019Reilly CL, Chen TF. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm. 2014;36(2):222\u2013232."},{"key":"JPPT-25-00102-b16","article-title":"Pharmacists on mental health teams benefit youth","author":"Sartain","year":"2022","unstructured":"American Pharmacists Association [APhA]. Sartain M. Pharmacists on mental health teams benefit youth. Washington, DC: 2022. Published April 11, 2022. Accessed April 9, 2025. https:\/\/www.pharmacist.com\/Publications\/Transitions\/pharmacists-on-mental-health-teams-benefit-youth"},{"issue":"3","key":"JPPT-25-00102-b17","series-title":"Pharm Pract (Granada)","first-page":"2545","article-title":"Pharmacists\u2019 roles in mental healthcare: past, present and future","volume":"19","author":"El-Den","year":"2021","unstructured":"El-Den S, Collins JC, Chen TF, O\u2019Reilly CL. Pharmacists\u2019 roles in mental healthcare: past, present and future. Pharm Pract (Granada). 2021;19(3):2545."},{"issue":"1","key":"JPPT-25-00102-b18","series-title":"Acad Emerg Med","first-page":"17","article-title":"Brief screening for adolescent depressive symptoms in the emergency department","volume":"15","author":"Rutman","year":"2008","unstructured":"Rutman MS, Shenassa E, Becker BM. Brief screening for adolescent depressive symptoms in the emergency department. Acad Emerg Med. 2008;15(1):17\u201322."},{"issue":"1","key":"JPPT-25-00102-b19","series-title":"Pediatrics","first-page":"e180","article-title":"Instruments to detect alcohol and other drug misuse in the emergency department: a systematic review","volume":"128","author":"Newton","year":"2011","unstructured":"Newton AS, Gokiert R, Mabood N, et al. Instruments to detect alcohol and other drug misuse in the emergency department: a systematic review. Pediatrics. 2011;128(1):e180\u2013e192."},{"issue":"12","key":"JPPT-25-00102-b20","series-title":"Arch Pediatr Adolesc Med","first-page":"1170","article-title":"Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department","volume":"166","author":"Horowitz","year":"2012","unstructured":"Horowitz LM, Bridge JA, Teach SJ, et al. Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department. Arch Pediatr Adolesc Med. 2012;166(12):1170\u20131176."},{"issue":"4","key":"JPPT-25-00102-b21","series-title":"Child Adolesc Psychiatr Clin N Am","first-page":"797","article-title":"Collaboration between child and adolescent psychiatrists and mental health pharmacists to improve treatment outcomes","volume":"30","author":"Lu","year":"2021","unstructured":"Lu DH, Dopheide JA, Wang D, et al. Collaboration between child and adolescent psychiatrists and mental health pharmacists to improve treatment outcomes. Child Adolesc Psychiatr Clin N Am. 2021;30(4):797\u2013808."},{"key":"JPPT-25-00102-b22","article-title":"Metabolic monitoring for children and adolescents on antipsychotics (APM)","year":"2024","unstructured":"National Committee for Quality Assurance [NCQA]. Metabolic monitoring for children and adolescents on antipsychotics (APM). Washington, DC: 2024. Accessed February 20, 2026. https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsychotics-apm"},{"key":"JPPT-25-00102-b23","article-title":"Metabolic monitoring for children and adolescents on antipsychotics (APM-E)","year":"2024","unstructured":"National Committee for Quality Assurance [NCQA]. Metabolic monitoring for children and adolescents on antipsychotics (APM-E). Washington, DC: 2024. Accessed February 20, 2026. https:\/\/www.ncqa.org\/report-cards\/healt-plans\/state-of-health-care-quality-report\/metabolic-monitoring-for-children-and-adolescents-on-antipsy\u00adchotics-apm-e"},{"issue":"7","key":"JPPT-25-00102-b24","series-title":"Can J Psychiatry","first-page":"645","article-title":"Long-term metabolic monitoring of youths treated with second-generation antipsychotics 5 years after publication of the CAMESA guidelines: are we making progress?","volume":"66","author":"Jazi","year":"2021","unstructured":"Jazi S, Ben-Amor L, Abadie P, et al. Long-term metabolic monitoring of youths treated with second-generation antipsychotics 5 years after publication of the CAMESA guidelines: are we making progress? Can J Psychiatry. 2021;66(7):645\u2013656."},{"issue":"6","key":"JPPT-25-00102-b25","series-title":"J Child Adolesc Psychopharmacol","first-page":"517","article-title":"Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents","volume":"21","author":"Maayan","year":"2011","unstructured":"Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2011;21(6):517\u2013535."},{"issue":"16","key":"JPPT-25-00102-b26","series-title":"JAMA","first-page":"1765","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765\u20131773."},{"issue":"10","key":"JPPT-25-00102-b27","series-title":"Curr Diab Rep","first-page":"96","article-title":"Association between antipsychotic medication use and diabetes","volume":"19","unstructured":"Holt RIG. Association between antipsychotic medication use and diabetes. Curr Diab Rep. 19(10):96."},{"issue":"6","key":"JPPT-25-00102-b28","series-title":"Pediatrics","first-page":"1135","article-title":"Antipsychotic medication use among children and risk of diabetes mellitus","volume":"128","author":"Andrade","year":"2011","unstructured":"Andrade SE, Lo JC, Roblin D, et al. Antipsychotic medication use among children and risk of diabetes mellitus. Pediatrics. 2011;128(6):1135\u20131141."},{"issue":"10","key":"JPPT-25-00102-b29","series-title":"JAMA Psychiatry","first-page":"1067","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","unstructured":"Bobo WV, Cooper WO, Stein CM, et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry. 2013;70(10):1067\u20131075."},{"issue":"5","key":"JPPT-25-00102-b30","series-title":"J Am Pharm Assoc (2003)","first-page":"e126","article-title":"Improvement of inpatient psychiatric facility quality reporting program measure: screening for metabolic disorders through pharmacy collaborative practice agreement","volume":"61","author":"Leung","year":"2021","unstructured":"Leung JG, Owen A, Webb AJ, et al. Improvement of inpatient psychiatric facility quality reporting program measure: screening for metabolic disorders through pharmacy collaborative practice agreement. J Am Pharm Assoc (2003). 2021;61(5):e126\u2013e131."},{"issue":"4","key":"JPPT-25-00102-b31","series-title":"Ment Health Clin","first-page":"248","article-title":"Impact of a pharmacist-driven tardive dyskinesia screening service","volume":"11","author":"Butala","year":"2021","unstructured":"Butala N, Williams A, Kneebusch J, Mitchell M. Impact of a pharmacist-driven tardive dyskinesia screening service. Ment Health Clin. 2021;11(4):248\u2013253."},{"issue":"7948","key":"JPPT-25-00102-b32","series-title":"Pharm J","article-title":"Assessing the integration of pharmacist independent prescribers in child and adolescent mental health services","volume":"306","author":"Shah","year":"2021","unstructured":"Shah C, Umaru N, Adams E, et al. Assessing the integration of pharmacist independent prescribers in child and adolescent mental health services. Pharm J. 2021;306(7948)."},{"issue":"2","key":"JPPT-25-00102-b33","series-title":"J Am Coll Clin Pharm","first-page":"149","article-title":"Role of board-certified psychiatric pharmacists in child and adolescent psychiatry","volume":"7","author":"Stutzman","year":"2024","unstructured":"Stutzman DL, Leiby LE, Temelie A, et al. Role of board-certified psychiatric pharmacists in child and adolescent psychiatry. J Am Coll Clin Pharm. 2024;7(2):149\u2013159."},{"key":"JPPT-25-00102-b34","article-title":"SBIRT: screening, brief intervention, and referral to treatment","year":"2024","unstructured":"Substance Abuse and Mental Health Services Administration [SAMHSA]. SBIRT: screening, brief intervention, and referral to treatment. Rockville, MD: 2024. Updated November 7, 2024. Accessed May 31, 2026. https:\/\/www.samhsa.gov\/substance-use\/treatment\/sbirt"},{"issue":"4","key":"JPPT-25-00102-b35","series-title":"Pediatrics","first-page":"e20182192","article-title":"Trends in psychiatric emergency department visits among youth and young adults in the US","volume":"143","author":"Kalb","year":"2019","unstructured":"Kalb LG, Stapp EK, Ballard ED, et al. Trends in psychiatric emergency department visits among youth and young adults in the US. Pediatrics. 2019;143(4):e20182192."},{"issue":"3","key":"JPPT-25-00102-b36","series-title":"Child Adolesc Psychiatr Clin N Am","first-page":"413","article-title":"An emergency department clinical pathway for children and youth with mental health conditions","volume":"27","author":"Jabbour","year":"2018","unstructured":"Jabbour M, Hawkins J, Day D, et al. An emergency department clinical pathway for children and youth with mental health conditions. Child Adolesc Psychiatr Clin N Am. 2018;27(3):413\u2013425."},{"key":"JPPT-25-00102-b37","article-title":"2024 Hospital National Patient Safety Goals","year":"2024","unstructured":"The Joint Commission. 2024 Hospital National Patient Safety Goals. Oakbrook Terrace, IL: 2024. Accessed May 15, 2025. https:\/\/www.jointcommission.org\/-\/media\/tjc\/documents\/standards\/national-patient-safety-goals\/2024\/hap-npsg-simple-2024-v2.pdf"},{"key":"JPPT-25-00102-b38","article-title":"National Patient Safety Goals\u00ae effective January 2024 for the behavioral health care and human services program","year":"2023","unstructured":"The Joint Commission. National Patient Safety Goals\u00ae effective January 2024 for the behavioral health care and human services program. Oakbrook Terrace, IL: 2023. Published October 4, 2023. Accessed April 11, 2025. https:\/\/www.jointcommission.org\/-\/media\/tjc\/documents\/standards\/national-patient-safety-goals\/2024\/npsg_chapter_bhc_jan2024.pdf"},{"key":"JPPT-25-00102-b39","article-title":"National Patient Safety Goals\u00ae effective January 2025 for the hospital program","year":"2024","unstructured":"The Joint Commission. National Patient Safety Goals\u00ae effective January 2025 for the hospital program. Oakbrook Terrace, IL: 2024. Published October 30, 2024. Accessed May 15, 2025. https:\/\/www.jointcommission.org\/-\/media\/tjc\/documents\/standards\/national-patient-safety-goals\/2025\/hap-npsg-chapter-2025.pdf"},{"key":"JPPT-25-00102-b40","article-title":"National Patient Safety Goals\u00ae effective January 2025 for the behavioral health care and human services program","year":"2024","unstructured":"The Joint Commission. National Patient Safety Goals\u00ae effective January 2025 for the behavioral health care and human services program. Oakbrook Terrace, IL: 2024. Published October 30, 2024. Accessed May 15, 2025. https:\/\/www.jointcommission.org\/standards\/national-patient-safety-goals\/behavioral-health-care-national-patient-safety-goals"},{"issue":"9","key":"JPPT-25-00102-b41","series-title":"Pediatr Emerg Care","first-page":"e538","article-title":"Antipsychiatric medication errors in children boarded in a pediatric emergency department","volume":"37","author":"Sethuraman","year":"2021","unstructured":"Sethuraman U, Kannikeswaran N, Farooqi A, et al. Antipsychiatric medication errors in children boarded in a pediatric emergency department. Pediatr Emerg Care. 2021;37(9):e538\u2013e542."},{"key":"JPPT-25-00102-b42","article-title":"Follow-up after emergency department visit for mental illness","year":"2024","unstructured":"National Committee for Quality Assurance [NCQA]. Follow-up after emergency department visit for mental illness. Washington, DC: 2024. Accessed May 14, 2025. https:\/\/www.ncqa.org\/report-cards\/health-plans\/state-of-health-care-quality-report\/follow-up-after-emergency-department-visit-for-mental-illness-fum"},{"issue":"3","key":"JPPT-25-00102-b43","series-title":"Pediatrics","first-page":"e2022057383","article-title":"Follow-up after pediatric mental health emergency visits","volume":"151","author":"Hoffmann","year":"2023","unstructured":"Hoffmann JA, Krass P, Rodean J, et al. Follow-up after pediatric mental health emergency visits. Pediatrics. 2023;151(3):e2022057383."},{"issue":"4","key":"JPPT-25-00102-b44","series-title":"J Soc Serv Res","first-page":"485","article-title":"Barriers to pediatric mental healthcare access: qualitative insights from caregivers","volume":"48","author":"Toure","year":"2022","unstructured":"Toure DM, Kumar G, Walker C, et al. Barriers to pediatric mental healthcare access: qualitative insights from caregivers. J Soc Serv Res. 2022;48(4):485\u2013495."},{"key":"JPPT-25-00102-b45","series-title":"JACEP Open","first-page":"e13141","article-title":"Management of youth with suicidal ideation: challenges and best practices for emergency departments","volume":"5","author":"Santillanes","year":"2024","unstructured":"Santillanes G, Foster AA, Ishimine P, et al. Management of youth with suicidal ideation: challenges and best practices for emergency departments. JACEP Open. 2024;5:e13141."},{"issue":"6","key":"JPPT-25-00102-b46","series-title":"Acad Pediatr","first-page":"995","article-title":"On- and off-label atypical antipsychotic prescription trends across a nine-year period among adolescents pre- to post-COVID-19","volume":"24","author":"Costales","year":"2024","unstructured":"Costales B, Slama NE, Penfold RB, et al. On- and off-label atypical antipsychotic prescription trends across a nine-year period among adolescents pre- to post-COVID-19. Acad Pediatr. 2024;24(6):995\u20131000."},{"key":"JPPT-25-00102-b47","article-title":"Health Resources and Services Administration, Maternal and Child Health Bureau. Critical crossroads: pediatric mental health care in the emergency department: a care pathway resource toolkit","year":"2019","unstructured":"US Department of Health and Human Services. Health Resources and Services Administration, Maternal and Child Health Bureau. Critical crossroads: pediatric mental health care in the emergency department: a care pathway resource toolkit. Rockville, MD: US Department of Health and Human Services, 2019. Accessed April 15, 2025. https:\/\/www.hrsa.gov\/critical-crossroads"},{"key":"JPPT-25-00102-b48","series-title":"Front Psychiatry","first-page":"717","article-title":"Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment","volume":"11","author":"Boaden","year":"2020","unstructured":"Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment. Front Psychiatry. 2020;11:717."},{"key":"JPPT-25-00102-b49","series-title":"Front Psychiatry","first-page":"294","article-title":"The FDA \u201cblack box\u201d warning on antidepressant suicide risk in young adults: more harm than benefits?","volume":"10","author":"Fornaro","year":"2019","unstructured":"Fornaro M, Anastasia A, Valchera A, et al. The FDA \u201cblack box\u201d warning on antidepressant suicide risk in young adults: more harm than benefits? Front Psychiatry. 2019;10:294."},{"issue":"10","key":"JPPT-25-00102-b50","series-title":"Health Aff (Millwood)","first-page":"1360","article-title":"Intended and unintended outcomes after FDA pediatric antidepressant warnings: a systematic review","volume":"43","author":"Soumerai","year":"2024","unstructured":"Soumerai SB, Koppel R, Naci H, et al. Intended and unintended outcomes after FDA pediatric antidepressant warnings: a systematic review. Health Aff (Millwood). 2024;43(10):1360\u20131369."},{"key":"JPPT-25-00102-b51","article-title":"Pharmacists\u2019 patient care process","year":"2025","unstructured":"Joint Commission of Pharmacy Practitioners. Pharmacists\u2019 patient care process. May 20, 2025. Accessed July 10, 2026. https:\/\/jcpp.net\/wp-content\/uploads\/2018\/10\/Pharmacists-Patient-Care-Process-Document-2025.pdf"},{"issue":"1","key":"JPPT-25-00102-b52","series-title":"J Am Pharm Assoc","first-page":"22","article-title":"Development, implementation, and evaluation of a pharmacist-conducted screening program for depression","volume":"53","author":"Rosser","year":"2013","unstructured":"Rosser S, Frede S, Conrad WF, Heaton PC. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression. J Am Pharm Assoc. 2013;53(1):22\u201329."},{"issue":"9","key":"JPPT-25-00102-b53","series-title":"Res Social Adm Pharm","first-page":"828","article-title":"Pharmacist-led screening for mental illness: a systematic review","volume":"20","author":"Ou","year":"2024","unstructured":"Ou K, Gide DN, El-Den S, et al. Pharmacist-led screening for mental illness: a systematic review. Res Social Adm Pharm. 2024;20(9):828\u2013845."},{"issue":"5","key":"JPPT-25-00102-b54","series-title":"Pediatrics","first-page":"e20192757","article-title":". Mental health competencies for pediatric practice","volume":"144","year":"2019","unstructured":"American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health, Mental Health Leadership Work Group. Mental health competencies for pediatric practice. Pediatrics. 2019;144(5):e20192757."},{"issue":"4","key":"JPPT-25-00102-b55","series-title":"Pharm Pract (Granada)","first-page":"2102","article-title":"Pharmacy professionals' preparedness to use Mental Health First Aid (MHFA) behaviors","volume":"18","author":"Witry","year":"2020","unstructured":"Witry MJ, Fadare O, Pudlo A. Pharmacy professionals' preparedness to use Mental Health First Aid (MHFA) behaviors. Pharm Pract (Granada). 2020;18(4):2102."},{"issue":"5","key":"JPPT-25-00102-b56","series-title":"Pediatrics","first-page":"e20192758","article-title":". Achieving the pediatric mental health competencies","volume":"144","year":"2019","unstructured":"American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health, Mental Health Leadership Work Group. Achieving the pediatric mental health competencies. Pediatrics. 2019;144(5):e20192758."},{"issue":"10","key":"JPPT-25-00102-b57","series-title":"Int J Environ Res Public Health","first-page":"10967","article-title":"New roles for pharmacists in community mental health care: a narrative review","volume":"11","author":"Rubio-Valera","year":"2014","unstructured":"Rubio-Valera M, Chen TF, O\u2019Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967\u201310990."},{"issue":"4","key":"JPPT-25-00102-b58","series-title":"Am J Health Syst Pharm","first-page":"431","article-title":"ASHP]. ASHP guidelines on pharmacist-conducted patient education and counseling","volume":"54","year":"1997","unstructured":"American Society of Health-System Pharmacists [ASHP]. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997;54(4):431\u2013434."},{"issue":"5","key":"JPPT-25-00102-b59","series-title":"Am J Health Syst Pharm","first-page":"388","article-title":". ASHP statement on the pharmacist\u2019s role in public health","volume":"79","year":"2022","unstructured":"American Society of Health-System Pharmacists [ASHP]. ASHP statement on the pharmacist\u2019s role in public health. Am J Health Syst Pharm. 2022;79(5):388\u2013399."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/31\/5\/article-p689.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/31\/5\/article-p689.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/31\/5\/article-p689.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:05Z","timestamp":1791809465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/31\/5\/article-p689.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/jppt-25-00102","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}